Athos Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Athos Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-80,000	Closed	-$5.77M	–	171
2020 Q4	$5.77M	Buy	+80,000	New	+$4.19M	1.59%	15

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Athos Capital's BEAT Position: Q1 2021 in Review

Athos Capital sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 80,000 shares — an estimated $5.77M sold.

Athos Capital first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $5.77M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Athos Capital reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Athos Capital sold 80,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $5.77M.
Athos Capital first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Athos Capital's BioTelemetry, Inc. position peaked at $5.77M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Athos Capital's 13F filing for Q1 2021, filed 14 May 2021.